Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/23 17:20 | 2/27/23 | OMGA | Health | BioPrd | Biological Products, (No Diag | Flagship Pioneering Inc. | MA | T | P | 19,209 | 5.78 | 0 | 3,323 | 13 | 29,226 | I | |||||||||||||||
8/5/21 17:43 | 8/3/21 | OMGA | Health | BioPrd | Biological Products, (No Diag | Flagship Pioneering Inc. | MA | T | P.d | 20,000 | 17.00 | 0 | 1,176 | 45 | 3,815 | I | |||||||||||||||
8/5/21 17:41 | 8/3/21 | OMGA | Health | BioPrd | Biological Products, (No Diag | Flagship Pioneering Inc. | MA | T | P.d | 20,000 | 17.00 | 0 | 1,176 | 45 | 3,815 | I | |||||||||||||||
8/3/21 17:16 | 8/3/21 | OMGA | Health | BioPrd | Biological Products, (No Diag | Sawhney Roger | MA | O | CFO | P | 50 | 17.00 | 0 | 3 | New | 3 | D | ||||||||||||||
8/3/21 17:16 | 7/30/21 | OMGA | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | P.dm | 16,085 | 16.93 | 0 | 950 | 72 | 2,274 | D | |||||||||||||||
8/3/21 17:15 | 8/3/21 | OMGA | Health | BioPrd | Biological Products, (No Diag | Berry David A | MA | D | P | 902 | 17.00 | 0 | 53 | New | 53 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |